| 1 |
Wang D, Qiao C, Xiao M, et al. Integrative analysis of prognostic factors in Chinese core binding factor leukemia[J]. Biochem Biophys Res Commun, 2012, 428(3): 411-415.
|
| 2 |
Spirin PV, Nikitenko NA, Lebedev TD, et al. Prasolova modulation of activated oncogene c-kit expression with RNA interference[J]. Mol Biol(Mosk), 2011, 45(6): 950-958.
|
| 3 |
Wang H, Boussouar A, Mazelin L, et al. The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor[J]. Mol Cell, 2018, 72(3): 413-425. e5.
|
| 4 |
Fu Shuang, Hu Yanping, Chen Fang, et al. Detection of c-kit mutations in acute myeloid leukemia patients with ETO or CBFβ positive and its clinical significance[J]. Journal of Modern Oncology, 2015, 23(11): 1581-1584.
|
| 5 |
方海同, 张波, 周光飚. C-KIT/Hsp90/Apaf-1信号通路在t(8;21)白血病细胞凋亡中的机制研究//第13届全国实验血液学会议论文集 [C]. 武汉, 2011: 104-105.
|
| 6 |
Faber ZJ, Chen X, Gedman AL, et al. The genomic landscape of core-binding factor acute myeloid leukemias[J]. Nat Genet, 2016, 48(12): 1551-1556.
|
| 7 |
Jung CL, Kim HJ, Kim DH, et al. C-KIT mutation in therapy-related acute myeloid leukemia with MLLT3/MLL chimeric transcript from t(9;11)(p22;q23)[J]. Ann Clin Lab Sci, 2011, 41(2): 193-196.
|
| 8 |
Schnittger S, Kohl TM, Haferlach T, et al. KIT- D816 mutations in AML1 -ETO -positive AML are associated with impaired event -free and overall survival[J]. Blood, 2006, 107(5): 1791-1799.
|
| 9 |
Klein K, Kaspers G, Harrison CJ, et al. Clinical impact of additional cytogenetic aberrations, cKIT and RAS Mutations, and treatment elements in pediatric t(8; 21)-AML: results from an international retrospective study by the international berlin-frank furt-münster study group[J]. J Clin Oncol, 2015, 36(33): 4247-4258.
|
| 10 |
Nishioka C, Ikezoe T, Yang J, et al. Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo[J]. Blood, 2008, 111(10): 5086-5092.
|
| 11 |
Lv M, Ou R, Zhang Q, et al. MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit[J]. Drug Des Devel Ther, 2019, 13: 2371-2379.
|
| 12 |
Rulina AV, Spirin PV, Prassolov VS. Activated leukemic oncogenes AML1-ETO and c-kit: role in development of acute myeloid leukemia and current approaches for their inhibition[J]. Biochemistry(Mosc), 2010, 75(13): 1650-1666.
|
| 13 |
孙晶, 赵艳红, 周晋. 达沙替尼治疗核心结合因子相关性急性髓系白血病的理论基础及最新临床研究[J]. 中国新药杂志, 2015, 24(9): 1013-1016.
|
| 14 |
靖彧, 朱成英, 张琪, 等. 地西他滨联合改良CAG方案治疗AML1-ETO阳性复发、难治急性髓系白血病的临床研究[J]. 中国实验血液学杂志, 2014, 22(5): 1245-1250.
|